Enterprise Interest Nothing to declare

Size: px
Start display at page:

Download "Enterprise Interest Nothing to declare"

Transcription

1 Enterprise Interest Nothing to declare

2 A rare cause of myopathy in adults Jorge Pinheiro MD, José Manuel Lopes MD, PhD Joint Slide Seminar Electron Microscopy and Trainees: Understanding diseases through the "big eye": an ultrastructural pathology seminar by pathologists in training

3 Clinical presentation 60 year-old woman Main complaints Progressive muscle weakness during one year, affecting predominantly proximal limb muscles and the neck, disclosing "drop head" Mild disphagia and horseness Muscle pain 10 kg weight loss Past & family history No relevant medical history Parents were consanguineous (cousins in 3rd degree) No relevant family history of neurological disease

4 Physical examination Myopatic gait and drop head Proximal predominant tetraparesia Muscle Group Superior limb Inferior limb Neck proximal distal proximal distal Mild facial muscle paresia Muscle atrophy No ptosis nor diplopia No sensorial alterations flexion / extensio n Grade G3 G4+ G4+ G5 G3

5 Ancilary studies Electromyography (EMG): myopathic tracings (as shown in B) in the proximal muscles of the inferior limbs and in the proximal and distal muscles of the upper limbs, with more severe alterations in the proximal muscles. A normal EMG B myopatic EMG ECG and cardiac ecography: normal Spirometry: normal

6 Ancilary studies Cell blood count: mild bicytopenia with leucopenia (2920/mm 3 ) and thrombocytopenia (133000/mm 3 ) albumin α 1 α 2 ß γ Protein electrophoresis: monoclonal gamopathy Immunofixation: Monoclonal gamopathy with lambda chains

7 Ancilary studies CK, aldolase and myoglobulin: normal TSH normal Immunological study was unremarkable ANA, anti-dsdna AMA anti-neuronal anti-ena panel HIV, HCV, HBV: negative

8 Muscle biopsy (deltoid muscle) H&E

9 ATPase ph 4.35 ATPase ph 9.4

10 Gomori

11 SDH COX

12 Tuloidine blue (x400)

13 Myotilin (IHC

14

15

16

17 Diagnosis Adult-onset nemalinic myopathy (SLONM) assotiated with monoclonal gamopathy

18 Follow-up of the patient Muscle weakness Drop-head Muscle pain 10 kg weight loss Worsening of the muscle weakness in the acute phase Jan Jan Feb July 2017 Melphalan Autologous stem-cell transplantatio n Clinical stability of symptoms Persistence of monoclonal gamopathy Lenalidomide

19 Clinical classification of nemaline myopathy (by disease onset and severity of motor and respiratory involvement) Severe congenital (neonatal) (16%) Amish NM Intermediate congenital (20%) Typical congenital (46%) Childhood-onset (13%) SLONM (4%)* Ryan MM et al * The pathogenesis remains to be clarified

20 Frequency of genetic / phenotypic features and inheritance mode of nemaline myopathies Gene Frequency Inheritance Phenotype NEB Up to 50% AR Typical congenital (majority), and other ACTA % AD/AR Range from severe congenital to childhood onset Causes 50% of severe lethal NM TPM3 2%-3% AD/AR Severe (AR), intermediate and childhood (AD) TPM2 <1% AD Typical congenital TNNT1 Old Amish AR Amish NM CFL2 Rare AR Typical congenital KBTBD1 3 unknown AD Childhood onset, slowly progressive KLHL40 unknown AR Severe congenital lethal (fetal akhinesia) KLHL41 unknown AR Severe, intermediate and typical congenital LMOD3 unknown AR Severe and typical congenital Winter JM, Ottenheijm CAC (2017) other na AR na adapted from North KM & Ryan MM,

21 Definition: rare acquired, late-onset muscle disorder, with subacute progression, characterized by proximal muscle weakness and atrophy, and nemaline rods in myofibers. Mean age at onset: 52 years (range 25-78)

22 SLOMN 19.7% HIV related Early age at onset Disease progression similar to other nemaline myopathies No facial or respiratory muscle involvement Frequent myonecrosis and inflammatory infiltrates 35.5 % MGUS related Worse prognosis, with rapid progession in 50% of cases (as in the present case)

23 References Malfatti, E. & Romero, N. B. Nemaline myopathies: State of the art. Revue Neurologique 172, (2016). Milone, M. et al. Sporadic late onset nemaline myopathy responsive to IVIg and immunotherapy. Muscle and Nerve 41, (2010) North KN, Ryan MM. Nemaline Myopathy Jun 19 [Updated 2015 Jun 11]. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews [Internet]. Seattle (WA): University of Washington, Seattle; Romero, N. B., Sandaradura, S. a & Clarke, N. F. Recent advances in nemaline myopathy. Curr. Opin. Neurol. 26, (2013). Ryan, M. M. et al. Nemaline myopathy: A clinical study of 143 cases. Ann. Neurol. 50, (2001). Schnitzler, L. J. et al. Sporadic late-onset nemaline myopathy: clinicopathological characteristics and review of 76 cases. Orphanet J. Rare Dis. 12, 86 (2017). Voermans, N. C. et al. Sporadic late-onset nemaline myopathy with MGUS; Long-term follow-up after melphalan and SCT. Neurology 83, (2014)

et al.. Rare myopathy associated to MGUS, causing heart failure and responding to chemotherapy.

et al.. Rare myopathy associated to MGUS, causing heart failure and responding to chemotherapy. Rare myopathy associated to MGUS, causing heart failure and responding to chemotherapy Nicolas Belhomme, Adel Maamar, Thomas Le Gallou, Marie-Christine Minot-Myhié, Antoine Larralde, Nicolas Champtiaux,

More information

Case 1: History of J.H. Outside Evaluation. Outside Labs. Question #1

Case 1: History of J.H. Outside Evaluation. Outside Labs. Question #1 Case 1: History of J.H. 64 yo man seen at UCSF 6-256 25-07. 9 months ago onset progressive weakness of arms and legs, with muscle atrophy in arms. 4 months ago red scaly rash on face, back of hands and

More information

Neonatal Hypotonia Guideline Prepared by Dan Birnbaum MD August 27, 2012

Neonatal Hypotonia Guideline Prepared by Dan Birnbaum MD August 27, 2012 Neonatal Hypotonia Guideline Prepared by Dan Birnbaum MD August 27, 2012 Hypotonia: reduced tension or resistance to range of motion Localization can be central (brain), peripheral (spinal cord, nerve,

More information

Clinical and pathologic aspects of congenital myopathies

Clinical and pathologic aspects of congenital myopathies Neurol J Southeast Asia 2001; 6 : 99 106 88 Clinical and pathologic aspects of congenital myopathies Ikuya NONAKA MD National Center of Neurology and Psychiatry, Kodaira, Tokyo, Japan Abstract The term

More information

Neonatal Hypotonia. Encephalopathy acute No encephalopathy. Neurology Chapter of IAP

Neonatal Hypotonia. Encephalopathy acute No encephalopathy. Neurology Chapter of IAP The floppy infant assumes a frog legged position. On ventral suspension, the baby can not maintain limb posture against gravity and assumes the position of a rag doll. Encephalopathy acute No encephalopathy

More information

Result Navigator. Positive Test Result: PTEN. After a positive test result, there can be many questions about what to do next. Navigate Your Results

Result Navigator. Positive Test Result: PTEN. After a positive test result, there can be many questions about what to do next. Navigate Your Results Result Navigator Positive Test Result: PTEN Positive test results identify a change, or misspelling, of DNA that is known or predicted to cause an increased risk for cancer. DNA is the blueprint of life

More information

Tel: , Fax: ,

Tel: , Fax: , 1 Nemaline Myopathy Type 2 (NEM2): Two Novel Mutations in the Nebulin (NEB) Gene Anna Gajda MD 1*, Emese Horváth MD 2*, Tibor Hortobágyi MD, PhD 3, Gyurgyinka Gergev MA 1,4, Hajnalka Szabó MD, PhD 1, Katalin

More information

Anesthesia recommendations for patients suffering from Welander distal myopathy

Anesthesia recommendations for patients suffering from Welander distal myopathy orphananesthesia Anesthesia recommendations for patients suffering from Welander distal myopathy Disease name: Welander distal myopathy ICD 10: G71.0 Synonyms: late adult onset type 1 distal myopathy;

More information

Lactic Acidosis and Ascending Neuromuscular Syndrome. Mina Hosseinipour, M.D, MPH. University of North Carolina Project, Lilongwe Malawi

Lactic Acidosis and Ascending Neuromuscular Syndrome. Mina Hosseinipour, M.D, MPH. University of North Carolina Project, Lilongwe Malawi Lactic Acidosis and Ascending Neuromuscular Syndrome Mina Hosseinipour, M.D, MPH. University of North Carolina Project, Lilongwe Malawi Introduction ART is rapidly scaling up in resource poor countries

More information

Diseases of Muscle and Neuromuscular Junction

Diseases of Muscle and Neuromuscular Junction Diseases of Muscle and Neuromuscular Junction Diseases of Muscle and Neuromuscular Junction Neuromuscular Junction Muscle Myastenia Gravis Eaton-Lambert Syndrome Toxic Infllammatory Denervation Atrophy

More information

ORIGINAL ARTICLE Evaluation of One Hundred Pediatric Muscle Biopsies During A 2-Year Period in Mofid Children And Toos Hospitals

ORIGINAL ARTICLE Evaluation of One Hundred Pediatric Muscle Biopsies During A 2-Year Period in Mofid Children And Toos Hospitals ORIGINAL ARTICLE Evaluation of One Hundred Pediatric Muscle Biopsies During A 2-Year Period in Mofid Children And Toos Hospitals How to Cite This Article: : Nilipor Y, Shariatmadari F, Abdollah gorji F,

More information

Patient L.L. KRISTEN ARREDONDO, MD CHILD NEUROLOGY PGY5, UT SOUTHWESTERN

Patient L.L. KRISTEN ARREDONDO, MD CHILD NEUROLOGY PGY5, UT SOUTHWESTERN Patient L.L. KRISTEN ARREDONDO, MD CHILD NEUROLOGY PGY5, UT SOUTHWESTERN Birth History LL was born to a healthy first time mother with an uncomplicated pregnancy Delivered at 38 weeks via C-section due

More information

Stage I: Rule-Out Dashboard Secondary Findings in Adults

Stage I: Rule-Out Dashboard Secondary Findings in Adults Stage I: Rule-Out Dashboard GENE/GENE PANEL: DNM2 DISORDER: DNM2-Related Intermediate Charcot-Marie-Tooth Neuropathy HGNC ID: 2974 OMIM ID: 606482 ACTIONABILITY PENETRANCE 1. Is there a qualifying resource,

More information

Genetic Testing for Neurologic Disorders

Genetic Testing for Neurologic Disorders Genetic Testing for Neurologic Disorders MP9497 Covered Service: Prior Authorization Required: Additional Information: Yes when meets criteria below Yes as shown below Pre- and post-test genetic counseling

More information

Nemaline (rod) myopathies

Nemaline (rod) myopathies Nemaline (rod) myopathies Nemaline, or rod, myopathies are a group of conditions which fall under the umbrella of congenital myopathies. They are characterised by rod-like structures in the muscle cells,

More information

Case 1 A 65 year old college professor came to the neurology clinic referred by her family physician because of frequent falling. She had a history of

Case 1 A 65 year old college professor came to the neurology clinic referred by her family physician because of frequent falling. She had a history of Peripheral Nervous System Case 1 A 65 year old college professor came to the neurology clinic referred by her family physician because of frequent falling. She had a history of non-insulin dependent diabetes

More information

Genetic diagnosis of limb girdle muscular dystrophy type 2A, A Case Report

Genetic diagnosis of limb girdle muscular dystrophy type 2A, A Case Report Genetic diagnosis of limb girdle muscular dystrophy type 2A, A Case Report Roshanak Jazayeri, MD, PhD Assistant Professor of Medical Genetics Faculty of Medicine, Alborz University of Medical Sciences

More information

Immunohistochemical Study of Dystrophin Associated Glycoproteins in Limb-girdle Muscular Dystrophies

Immunohistochemical Study of Dystrophin Associated Glycoproteins in Limb-girdle Muscular Dystrophies Dystrophin Immunohistochemical Study of Dystrophin Associated Glycoproteins in Limb-girdle Muscular Dystrophies NSC 89-2314-B-002-111 88 8 1 89 7 31 ( Peroxidase -AntiPeroxidase Immnofluorescence) Abstract

More information

Muscle Pathology Surgical Pathology Unknown Conference. November, 2008 Philip Boyer, M.D., Ph.D.

Muscle Pathology Surgical Pathology Unknown Conference. November, 2008 Philip Boyer, M.D., Ph.D. Muscle Pathology Surgical Pathology Unknown Conference November, 2008 Philip Boyer, M.D., Ph.D. Etiologic Approach to Differential Diagnosis Symptoms / Signs / Imaging / Biopsy / CSF Analysis Normal Abnormal

More information

A Tale of Five Demyelinating Neuropathies

A Tale of Five Demyelinating Neuropathies Objectives A Tale of Five Demyelinating Neuropathies Tahseen Mozaffar, MD FAAN Professor and Vice Chair of Neurology Director, UC Irvine-MDA ALS and Neuromuscular Center Director, Neurology Residency Training

More information

Result Navigator. Positive Test Result: RAD51C. After a positive test result, there can be many questions about what to do next. Navigate Your Results

Result Navigator. Positive Test Result: RAD51C. After a positive test result, there can be many questions about what to do next. Navigate Your Results Result Navigator Positive Test Result: RAD51C Positive test results identify a change, or misspelling, of DNA that is known or predicted to cause an increased risk for cancer. DNA is the blueprint of life

More information

Profile, types, duration and severity of muscular dystrophy: a clinical study at a tertiary care hospital

Profile, types, duration and severity of muscular dystrophy: a clinical study at a tertiary care hospital International Journal of Advances in Medicine Viswajyothi P et al. Int J Adv Med. 2018 Jun;5(3):700-704 http://www.ijmedicine.com pissn 2349-3925 eissn 2349-3933 Original Research Article DOI: http://dx.doi.org/10.18203/2349-3933.ijam20182126

More information

EDX in Myopathies Limitations. EDX in Myopathies Utility Causes of Myopathy. Myopathy: Issues for Electromyographers

EDX in Myopathies Limitations. EDX in Myopathies Utility Causes of Myopathy. Myopathy: Issues for Electromyographers Electrodiagnostic Assessment of Myopathy Myopathy: Issues for Electromyographers Often perceived as challenging Ian Grant Division of Neurology QEII Health Sciences Centre Halifax NS CNSF EMG Course June

More information

1 DOS CME Course 2011

1 DOS CME Course 2011 Statin Myopathy February 23, 2011 Jinny Tavee, MD Associate Professor Neurological Institute Cleveland Clinic Foundation 1 Case 1 50 y/o woman with hyperlipidemia presents with one year history of deep

More information

The Internist s Approach to Neuropathy

The Internist s Approach to Neuropathy The Internist s Approach to Neuropathy VOLKAN GRANIT, MD, MSC ASSISTANT PROFESSOR OF NEUROLOGY NEUROMUSCU LAR DIVISION UNIVERSITY OF MIAMI, MILLER SCHOOL OF MEDICINE RELEVANT DECLARATIONS Financial disclosures:

More information

Result Navigator. Positive Test Result: CDH1. After a positive test result, there can be many questions about what to do next. Navigate Your Results

Result Navigator. Positive Test Result: CDH1. After a positive test result, there can be many questions about what to do next. Navigate Your Results Result Navigator Positive Test Result: CDH1 Positive test results identify a change, or misspelling, of DNA that is known or predicted to cause an increased risk for cancer. DNA is the blueprint of life

More information

Neuromuscular in the Pediatric Clinic: Recognition and Referral

Neuromuscular in the Pediatric Clinic: Recognition and Referral Neuromuscular in the Pediatric Clinic: Recognition and Referral Matthew Harmelink, MD Assistant Professor, Pediatric Neurology Medical College of Wisconsin Objectives: 1. Understand common presentations

More information

Result Navigator. Positive Test Result: MEN1. After a positive test result, there can be many questions about what to do next. Navigate Your Results

Result Navigator. Positive Test Result: MEN1. After a positive test result, there can be many questions about what to do next. Navigate Your Results Result Navigator Positive Test Result: MEN1 Positive test results identify a change, or misspelling, of DNA that is known or predicted to cause an increased risk for cancer. DNA is the blueprint of life

More information

Congenital myopathies: clinical phenotypes and new diagnostic tools

Congenital myopathies: clinical phenotypes and new diagnostic tools Cassandrini et al. Italian Journal of Pediatrics (2017) 43:101 DOI 10.1186/s13052-017-0419-z REVIEW Congenital myopathies: clinical phenotypes and new diagnostic tools Open Access Denise Cassandrini 1,

More information

Critical Illness Polyneuropathy CIP and Critical Illness Myopathy CIM. Andrzej Sladkowski

Critical Illness Polyneuropathy CIP and Critical Illness Myopathy CIM. Andrzej Sladkowski Critical Illness Polyneuropathy CIP and Critical Illness Myopathy CIM Andrzej Sladkowski Potential causes of weakness in the ICU-1 Muscle disease Critical illness myopathy Inflammatory myopathy Hypokalemic

More information

A Practical Approach to Polyneuropathy SLOCUM DICKSON ANNUAL TEACHING DAY NOVEMBER 4, 2017

A Practical Approach to Polyneuropathy SLOCUM DICKSON ANNUAL TEACHING DAY NOVEMBER 4, 2017 A Practical Approach to Polyneuropathy SLOCUM DICKSON ANNUAL TEACHING DAY NOVEMBER 4, 2017 Disclosures Research support from Cytokinetics, Inc Catalyst, Inc Editorial fees from UptoDate. Objectives Describe

More information

Disorders of Muscle. Disorders of Muscle. Muscle Groups Involved in Myopathy. Needle Examination of EMG. History. Muscle Biopsy

Disorders of Muscle. Disorders of Muscle. Muscle Groups Involved in Myopathy. Needle Examination of EMG. History. Muscle Biopsy Disorders of Muscle Disorders of Muscle Zakia Bell, M.D. Associate Professor of Neurology and Physical Medicine & Rehabilitation Virginia Commonwealth University Cardinal symptom of diseases of the muscle

More information

Case Studies in Peripheral Neurophysiology. Elliot L. Dimberg Mayo Clinic Florida 2015 American Clinical Neurophysiology Society Annual Meeting

Case Studies in Peripheral Neurophysiology. Elliot L. Dimberg Mayo Clinic Florida 2015 American Clinical Neurophysiology Society Annual Meeting Case Studies in Peripheral Neurophysiology Elliot L. Dimberg Mayo Clinic Florida 2015 American Clinical Neurophysiology Society Annual Meeting Disclosures None Goals and Objectives To provide a concise,

More information

Jo Abraham MD Division of Nephrology University of Utah

Jo Abraham MD Division of Nephrology University of Utah Jo Abraham MD Division of Nephrology University of Utah 68 year old male presented 3 weeks ago with a 3 month history of increasing fatigue He reported a 1 week history of increasing dyspnea with a productive

More information

A Hypothesis Driven Approach to the Neurological Exam

A Hypothesis Driven Approach to the Neurological Exam A Hypothesis Driven Approach to the Neurological Exam Vanja Douglas, MD Assistant Clinical Professor UCSF Department of Neurology Disclosures None 1 Purpose of Neuro Exam Screen asymptomatic patients Screen

More information

Pediatric Aspects of EDX

Pediatric Aspects of EDX Pediatric Aspects of EDX Albert C. Clairmont, MD Associate Professor-Clinical The Ohio State University February 25, 2013 Objectives Overview of Pediatric Electrodiagnosis (EDX) Understand the different

More information

Result Navigator Positive Test Result: MSH6

Result Navigator Positive Test Result: MSH6 Result Navigator Positive Test Result: MSH6 Positive test results identify a change, or misspelling, of DNA that is known or predicted to cause an increased risk for cancer. DNA is the blueprint of life

More information

This is a repository copy of A novel mutation in the FGD4 gene causing Charcot-Marie-Tooth disease..

This is a repository copy of A novel mutation in the FGD4 gene causing Charcot-Marie-Tooth disease.. This is a repository copy of A novel mutation in the FGD4 gene causing Charcot-Marie-Tooth disease.. White Rose Research Online URL for this paper: http://eprints.whiterose.ac.uk/117077/ Version: Accepted

More information

Result Navigator. Positive Test Result: BMPR1A. After a positive test result, there can be many questions about what to do next. Navigate Your Results

Result Navigator. Positive Test Result: BMPR1A. After a positive test result, there can be many questions about what to do next. Navigate Your Results Result Navigator Positive Test Result: BMPR1A Positive test results identify a change, or misspelling, of DNA that is known or predicted to cause an increased risk for cancer. DNA is the blueprint of life

More information

Jonathan Katz, MD CPMC

Jonathan Katz, MD CPMC Jonathan Katz, MD CPMC Jonathan Katz, MD CPMC Jonathan Katz, MD CPMC Jonathan Katz, MD CPMC First, a bit of background Classic CIDP--TREATABLE MADSAM/Asymmetric Neuropathy Chronic Length Dependent Neuropathy-

More information

5.1 Alex.

5.1 Alex. 5.1 Alex http://tinyurl.com/neuromakessense Alex is a 20-year-old full-time national serviceman. His only past medical history is asthma, presents to A&E with a 4-day history of bilateral finger weakness

More information

Genetics of Inclusion Body Myositis

Genetics of Inclusion Body Myositis Genetics of Inclusion Body Myositis Thomas Lloyd, MD, PhD Associate Professor of Neurology and Neuroscience Co-director, Johns Hopkins Myositis Center Sporadic IBM (IBM) Age at onset usually > 50 Prevalence

More information

Evaluation of Peripheral Neuropathy. Evaluation of Peripheral Neuropathy - Introduction

Evaluation of Peripheral Neuropathy. Evaluation of Peripheral Neuropathy - Introduction Evaluation of Peripheral Neuropathy Chris Edwards, MD Ochsner Neurology, Main Campus Evaluation of Peripheral Neuropathy - Introduction A very common complaint in the clinic Presentation is variable Multiple

More information

DSS-1. No financial disclosures

DSS-1. No financial disclosures DSS-1 No financial disclosures Clinical History 9 year old boy with past medical history significant for cerebral palsy, in-turning right foot, left clubfoot that was surgically corrected at 3 years of

More information

Clinical and genetic heterogeneity in nemaline myopathy a disease of skeletal muscle thin filaments

Clinical and genetic heterogeneity in nemaline myopathy a disease of skeletal muscle thin filaments 362 Review 58 Braun, C. et al. (1999) Expression of calpain I messenger RNA in human renal cell carcinoma: correlation with lymph node metastasis and histological type. Int. J. Cancer 84, 6 9 59 Shiba,

More information

Long term history of a congenital core-rod myopathy with compound heterozygous mutations in the Nebulin gene

Long term history of a congenital core-rod myopathy with compound heterozygous mutations in the Nebulin gene Acta Myologica 2018; XXXVII: p. 121-127 Long term history of a congenital core-rod myopathy with compound heterozygous mutations in the Nebulin gene Gilbert Wunderlich 1, Anna Brunn 2, Hülya-Sevcan Daimagüler

More information

Critical Illness Neuropathy

Critical Illness Neuropathy Critical Illness Neuropathy JILL McEWEN, MD FRCPC Clinical Professor & Director Undergraduate Education Program Department of Emergency Medicine University of British Columbia Vancouver, BC Canada Immediate

More information

Distal chronic spinal muscular atrophy involving the hands

Distal chronic spinal muscular atrophy involving the hands Journal ofneurology, Neurosurgery, and Psychiatry, 1978, 41, 653-658 Distal chronic spinal muscular atrophy involving the hands D. J. O'SULLIVAN AND J. G. McLEOD From St Vincent's Hospital, and Department

More information

An Overview of Congenital Myopathies Jean K. Mah, MD, MSc, FRCPC; Jeffrey T. Joseph, MD, PhD

An Overview of Congenital Myopathies Jean K. Mah, MD, MSc, FRCPC; Jeffrey T. Joseph, MD, PhD Review Article Downloaded from https://journals.lww.com/continuum by maxwo3znzwrcfjddvmduzvysskax4mzb8eymgwvspgpjoz9l+mqfwgfuplwvy+jmyqlpqmifewtrhxj7jpeo+505hdqh14pdzv4lwky42mcrzqckilw0d1o4yvrwmuvvhuyo4rrbviuuwr5dqytbtk/icsrdbt0hfryk7+zagvaltkgnudxdohhaxffu/7kno26hifzu/+bcy16w7w1bdw==

More information

Myopathy in Post-Radiation Cervico-Scapular Syndrome

Myopathy in Post-Radiation Cervico-Scapular Syndrome http://escholarship.umassmed.edu/neurol_bull Myopathy in Post-Radiation Cervico-Scapular Syndrome Anna Kogan, Galyna Pushchinska, and Roberta Seidman Department of Neurology Stony Brook University Hospital

More information

Guide to the use of nerve conduction studies (NCS) & electromyography (EMG) for non-neurologists

Guide to the use of nerve conduction studies (NCS) & electromyography (EMG) for non-neurologists Guide to the use of nerve conduction studies (NCS) & electromyography (EMG) for non-neurologists What is NCS/EMG? NCS examines the conduction properties of sensory and motor peripheral nerves. For both

More information

Amyloid neuropathy: (A) scattered Congo Red positive material in endoneurium displays apple green birefringence under polarized light.

Amyloid neuropathy: (A) scattered Congo Red positive material in endoneurium displays apple green birefringence under polarized light. Cơ vân Cơ vân Cơ vân (cắt dọc) Amyloid neuropathy: (A) scattered Congo Red positive material in endoneurium displays apple green birefringence under polarized light. (A, Congo Red). Amyloid neuropathy:

More information

Diagnosis of McArdle's disease in an elderly patient: Case report and review of literature

Diagnosis of McArdle's disease in an elderly patient: Case report and review of literature ISPUB.COM The Internet Journal of Neurology Volume 9 Number 1 Diagnosis of McArdle's disease in an elderly patient: Case report and review of literature R Makary, A Berger, N Talpur, S Shuja Citation R

More information

AII-type: Select the most appropriate answer

AII-type: Select the most appropriate answer AII-type: Select the most appropriate answer ( )1. Choose one best answer for the following pathologic pictures. A. choroid cyst B. choroid papilloma C. pontine glioma D. ependymoma E. metastatic tumor

More information

The many faces of myositis. Marianne de Visser Academic Medical Centre Dept of Neurology Amsterdam The Netherlands

The many faces of myositis. Marianne de Visser Academic Medical Centre Dept of Neurology Amsterdam The Netherlands The many faces of myositis Marianne de Visser Academic Medical Centre Dept of Neurology Amsterdam The Netherlands Outline of the presentation Classification Diagnosis Therapy Prognosis Diagnostic criteria

More information

Result Navigator. Positive Test Result: STK11. After a positive test result, there can be many questions about what to do next. Navigate Your Results

Result Navigator. Positive Test Result: STK11. After a positive test result, there can be many questions about what to do next. Navigate Your Results Result Navigator Positive Test Result: STK11 Positive test results identify a change, or misspelling, of DNA that is known or predicted to cause an increased risk for cancer. DNA is the blueprint of life

More information

Human Physiology Lab (Biol 236L) Fall, 2015

Human Physiology Lab (Biol 236L) Fall, 2015 1 Human Physiology Lab (Biol 236L) Fall, 2015 Name: Nursing Case Study: Muscle Weakness Chief Complaint: A 26-year-old woman with muscle weakness in the face. Patient Presentation: A 26-year-old woman

More information

Peripheral neuropathies, neuromuscular junction disorders, & CNS myelin diseases

Peripheral neuropathies, neuromuscular junction disorders, & CNS myelin diseases Peripheral neuropathies, neuromuscular junction disorders, & CNS myelin diseases Peripheral neuropathies according to which part affected Axonal Demyelinating with axonal sparing Many times: mixed features

More information

Making sense of Nerve conduction & EMG

Making sense of Nerve conduction & EMG Making sense of Nerve conduction & EMG Drs R Arunachalam Consultant Clinical Neurophysiologist Wessex Neurological Centre Southampton University Hospital EMG/NCS EMG machine For the assessment of patients

More information

CIDP + MMN - how to diagnose and treat. Dr Hadi Manji

CIDP + MMN - how to diagnose and treat. Dr Hadi Manji CIDP + MMN - how to diagnose and treat Dr Hadi Manji Outline Introduction CIDP Diagnosis Clinical features MRI Nerve conduction tests Lumbar puncture Nerve biopsy Treatment IV Ig Steroids Plasma Exchnage

More information

Test Information Sheet

Test Information Sheet Prenatal Lissencephaly Panel Sequence Analysis and Exon-Level Deletion/Duplication Testing* of 24 Genes Panel Gene List: ACTB, ACTG1, X, ATP6V0A2, B3GALNT2*, B4GAT1*, DCX, FKRP*, FKTN, GMPPB*, ISPD, LAMB1,

More information

CONTENT ANATOMIC LOCI OF NM DISEASE ASSOCIATED FEATURES FUNCTIONAL DIFFICULTIES. CLINICAL HISTORY IN NEUROMUSCULAR DISEASES Weakness 06/11/60

CONTENT ANATOMIC LOCI OF NM DISEASE ASSOCIATED FEATURES FUNCTIONAL DIFFICULTIES. CLINICAL HISTORY IN NEUROMUSCULAR DISEASES Weakness 06/11/60 CONTENT HOW TO APPROACH LIMB GIRDLE AND NON-LIMB GIRDLE WEAKNESS Kongkiat Kulkantrakorn, M.D. Professor Thammasat University Clinical approach in NM disease and phenotype Common and uncommon LGMDs Common

More information

4/16/2018. Demystifying weakness: how to approach refractory myositis. Objectives. Disclosures. Off-label uses for medications will be discussed

4/16/2018. Demystifying weakness: how to approach refractory myositis. Objectives. Disclosures. Off-label uses for medications will be discussed Demystifying weakness: how to approach refractory myositis Jemima Albayda, MD Assistant Professor Johns Hopkins Myositis center Disclosures Off-label uses for medications will be discussed Objectives To

More information

Clinical Aspects of Peripheral Nerve and Muscle Disease. Roy Weller Clinical Neurosciences University of Southampton School of Medicine

Clinical Aspects of Peripheral Nerve and Muscle Disease. Roy Weller Clinical Neurosciences University of Southampton School of Medicine Clinical Aspects of Peripheral Nerve and Muscle Disease Roy Weller Clinical Neurosciences University of Southampton School of Medicine Normal Nerves 1. Anterior Horn Cell 2. Dorsal root ganglion cell 3.

More information

Inclusion body myositis

Inclusion body myositis Pathology Feature William R. Hart, M.D. Section Editor Inclusion body myositis A possible chronic persistent muscle infection mumps virus 1 Samuel M. Chou, M.D., Ph.D. Inclusion body myositis was diagnosed

More information

Topics Covered. General muscle structure non-muscle components, macro-structure, contractile elements, membrane components.

Topics Covered. General muscle structure non-muscle components, macro-structure, contractile elements, membrane components. 1 Topics Covered General muscle structure non-muscle components, macro-structure, contractile elements, membrane components. Contractile function Contractile and regulatory proteins, force production.

More information

A family study of Charcot-Marie-Tooth disease

A family study of Charcot-Marie-Tooth disease Joturnal of Medical Genetics, 1982, 19, 88-93 A family study of Charcot-Marie-Tooth disease A P BROOKS* AND A E H EMERY From the University Department of Human Genetics, Western General Hospital, Edinburgh

More information

Diagnosis of ocular myopathy

Diagnosis of ocular myopathy Brit. J. Ophthal. (I 97I) 55, 633 Diagnosis of ocular myopathy MARGARET BARRIE Consultant Neurologist, St. Margaret's Hospital, Epping AND KENNETH HEATHFIELD Consultant Neurologist, Oldchurch Hospital,

More information

III./10.4. Diagnosis. Introduction. A.) Laboratory tests. Laboratory tests, electrophysiology, muscle biopsy, genetic testing, imaging techniques

III./10.4. Diagnosis. Introduction. A.) Laboratory tests. Laboratory tests, electrophysiology, muscle biopsy, genetic testing, imaging techniques III./10.4. Diagnosis Laboratory tests, electrophysiology, muscle biopsy, genetic testing, imaging techniques After studying this chapter, you will become familiar with the most commonly used diagnostic

More information

Original Science. Evaluation of Multiple Standard Laboratory Parameters in Amyotrophic Lateral Sclerosis

Original Science. Evaluation of Multiple Standard Laboratory Parameters in Amyotrophic Lateral Sclerosis Evaluation of Multiple Standard Laboratory Parameters in Amyotrophic Lateral Sclerosis Bandhu Paudyal, MBBS 1 ; Nabil Ahmad, MD 1 ; James B. Caress, MD 1 ; Leah P. Griffin, MS 2 ; and Michael S. Cartwright,

More information

1/28/2019. OSF HealthCare INI Care Center Team. Neuromuscular Disease: Muscular Dystrophy. OSF HealthCare INI Care Center Team: Who are we?

1/28/2019. OSF HealthCare INI Care Center Team. Neuromuscular Disease: Muscular Dystrophy. OSF HealthCare INI Care Center Team: Who are we? Neuromuscular Disease: Muscular Dystrophy Muscular Dystrophy Association (MDA) and OSF HealthCare Illinois Neurological Institute (INI) Care Center Team The Neuromuscular clinic is a designated MDA Care

More information

Diagnosis, management and new treatments for Spinal Muscular Atrophy Special Focus: SMA Type 1

Diagnosis, management and new treatments for Spinal Muscular Atrophy Special Focus: SMA Type 1 Diagnosis, management and new treatments for Spinal Muscular Atrophy Special Focus: SMA Type 1 17 th April 2018 Adnan Manzur Consultant Paediatric Neurologist Dubowitz Neuromuscular Centre, GOSH & ICH,

More information

FEP Medical Policy Manual

FEP Medical Policy Manual FEP Medical Policy Manual Effective Date: July 15, 2018 Related Policies: None Genetic Testing for PTEN Hamartoma Tumor Syndrome Description The PTEN hamartoma tumor syndrome (PHTS) includes several syndromes

More information

Spinal Muscular Atrophy: Case Study. Spinal muscular atrophy (SMA) is a fairly common genetic disorder, affecting

Spinal Muscular Atrophy: Case Study. Spinal muscular atrophy (SMA) is a fairly common genetic disorder, affecting Spinal Muscular Atrophy: Case Study Spinal muscular atrophy (SMA) is a fairly common genetic disorder, affecting approximately one in 6,000 babies. It is estimated that one in every 40 Americans carries

More information

Xenazine. Xenazine (tetrabenazine) Description

Xenazine. Xenazine (tetrabenazine) Description Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Xenazine Page: 1 of 5 Last Review Date: June 12, 2014 Xenazine Description Xenazine (tetrabenazine)

More information

Idiopathic inflammatory muscle diseases. Dr. Paul Etau Ekwom MBChB, MMED Kenyatta National Hospital, Nairobi-Kenya

Idiopathic inflammatory muscle diseases. Dr. Paul Etau Ekwom MBChB, MMED Kenyatta National Hospital, Nairobi-Kenya Idiopathic inflammatory muscle diseases. Dr. Paul Etau Ekwom MBChB, MMED Kenyatta National Hospital, Nairobi-Kenya I.W, 28 YRS, FEMALE SHOP STEWARD Referred to KNH on 16/06/09 from Thika Nursing Home Weakness

More information

Muscular Dystrophies. Pinki Munot Consultant Paediatric Neurologist Great Ormond Street Hospital Practical Neurology Study days April 2018

Muscular Dystrophies. Pinki Munot Consultant Paediatric Neurologist Great Ormond Street Hospital Practical Neurology Study days April 2018 Muscular Dystrophies Pinki Munot Consultant Paediatric Neurologist Great Ormond Street Hospital Practical Neurology Study days April 2018 Definition and classification Clinical guide to recognize muscular

More information

Shalini Mahajan, M.D. Director, LA Neuromuscular Center (LANMC) Attune Health, Beverly Hills, CA

Shalini Mahajan, M.D. Director, LA Neuromuscular Center (LANMC) Attune Health, Beverly Hills, CA Shalini Mahajan, M.D. Director, LA Neuromuscular Center (LANMC) Attune Health, Beverly Hills, CA Business Address LA Neuromuscular Center Attune Health 8750 Wilshire Blvd, Ste 350, Beverly Hills, CA 90211

More information

Differential Diagnosis of Neuropathies and Compression. Dr Ashwin Pinto Consultant Neurologist Wessex Neurological Centre

Differential Diagnosis of Neuropathies and Compression. Dr Ashwin Pinto Consultant Neurologist Wessex Neurological Centre Differential Diagnosis of Neuropathies and Compression Dr Ashwin Pinto Consultant Neurologist Wessex Neurological Centre Outline of talk Mononeuropathies median and anterior interosseous nerve ulnar nerve

More information

IVIG (intravenous immunoglobulin) Bivigam, Carimune NF, Flebogamma, Gammagard, Gammagard S/D, Gammaked, Gammaplex, Gamunex-C, Octagam, Privigen

IVIG (intravenous immunoglobulin) Bivigam, Carimune NF, Flebogamma, Gammagard, Gammagard S/D, Gammaked, Gammaplex, Gamunex-C, Octagam, Privigen Pre - PA Allowance None Prior-Approval Requirements Diagnoses Patient must have ONE of the following documented indications: 1. Primary Immunodeficiency Disease (PID) with ONE of the a. Hypogammaglobulinemia,

More information

Sheena Surindran Grand Rounds 2/15/11

Sheena Surindran Grand Rounds 2/15/11 Sheena Surindran Grand Rounds 2/15/11 Affects 5 12 person per million / year 5 10% associated with myeloma Median survival without treatment is 12 40 months Most commonly affected organs are kidney, heart

More information

REQUISITION FORM NOTE: ALL FORMS MUST BE FILLED OUT COMPLETELY FOR SAMPLE TO BE PROCESSED. Last First Last First

REQUISITION FORM NOTE: ALL FORMS MUST BE FILLED OUT COMPLETELY FOR SAMPLE TO BE PROCESSED. Last First Last First #: DEPARTMENT OF NEUROLOGY COLUMBIA COLLEGE OF PHYSICIANS & SURGEONS Room 4-420 630 West 168th Street, New York, NY 10032 Telephone #: 212-305-3947 Fax#: 212-305-3986 REQUISITION FORM NOTE: ALL FORMS MUST

More information

SURVEY OF DUCHENNE TYPE AND CONGENITAL TYPE OF MUSCULAR DYSTROPHY IN SHIMANE, JAPAN 1

SURVEY OF DUCHENNE TYPE AND CONGENITAL TYPE OF MUSCULAR DYSTROPHY IN SHIMANE, JAPAN 1 Jap. J. Human Genet. 22, 43--47, 1977 SURVEY OF DUCHENNE TYPE AND CONGENITAL TYPE OF MUSCULAR DYSTROPHY IN SHIMANE, JAPAN 1 Kenzo TAKESHITA,* Kunio YOSHINO,* Tadashi KITAHARA,* Toshio NAKASHIMA,** and

More information

Neurological Examination

Neurological Examination Neurological Examination Charles University in Prague 1st Medical Faculty and General University Hospital Neurological examination: Why important? clinical history taking and bedside examination: classical

More information

Pathology of Complement Mediated Renal Disease

Pathology of Complement Mediated Renal Disease Pathology of Complement Mediated Renal Disease Mariam Priya Alexander, MD Associate Professor of Pathology GN Symposium Hong Kong Society of Nephrology July 8 th, 2017 2017 MFMER slide-1 The complement

More information

Index. Note: Page numbers of article titles are in boldface type.

Index. Note: Page numbers of article titles are in boldface type. Neurol Clin N Am 20 (2002) 605 617 Index Note: Page numbers of article titles are in boldface type. A ALS. See Amyotrophic lateral sclerosis (ALS) Amyotrophic lateral sclerosis (ALS) active denervation

More information

High Yield Neurological Examination

High Yield Neurological Examination High Yield Neurological Examination Vanja Douglas, MD Sara & Evan Williams Foundation Endowed Neurohospitalist Chair Director, Neurohospitalist Division Associate Professor of Clinical Neurology UCSF Department

More information

YES NO UNKNOWN. Stage I: Rule-Out Dashboard Secondary Findings in Adults ACTIONABILITY PENETRANCE SIGNIFICANCE/BURDEN OF DISEASE NEXT STEPS

YES NO UNKNOWN. Stage I: Rule-Out Dashboard Secondary Findings in Adults ACTIONABILITY PENETRANCE SIGNIFICANCE/BURDEN OF DISEASE NEXT STEPS Stage I: Rule-Out Dashboard HGNC ID: 6998 OMIM ID: 134610 ACTIONABILITY PENETRANCE 1. Is there a qualifying resource, such as a practice guideline or systematic review, for the genetic condition? 2. Does

More information

Neuroanatomy of a Stroke. Joni Clark, MD Professor of Neurology Barrow Neurologic Institute

Neuroanatomy of a Stroke. Joni Clark, MD Professor of Neurology Barrow Neurologic Institute Neuroanatomy of a Stroke Joni Clark, MD Professor of Neurology Barrow Neurologic Institute No disclosures Stroke case presentations Review signs and symptoms Review pertinent exam findings Identify the

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Genetic Testing for the Diagnosis of Inherited Peripheral Neuropathy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_the_diagnosis_of_inherited_peripheral_neuropathy

More information

Chronic focal polymyositis in the adult

Chronic focal polymyositis in the adult Journal of Neurology, Neurosurgery, and Psychiatry, 1981, 44, 419-425 Chronic focal polymyositis in the adult N E BHARUCHA AND J A MORGAN-HUGHES From the Institute of Neurology, Queen Square, London S

More information

CNEMG. Myopathy, Stålberg. At rest denervation and spec spontaneous activity (myotonia, CRD, neuromyotonia) MUP number of fibres in recorded area

CNEMG. Myopathy, Stålberg. At rest denervation and spec spontaneous activity (myotonia, CRD, neuromyotonia) MUP number of fibres in recorded area clincial heredity biochem MYOPATHY biopsy Erik Stålberg Uppsala, Sweden imaging genetics Electrodes A B C MU D E Conc EMG signals from 2-15 muscle fibres CNEMG At rest denervation and spec spontaneous

More information

Title. CitationInternal Medicine, 46(8): Issue Date Doc URL. Type. File Information

Title. CitationInternal Medicine, 46(8): Issue Date Doc URL. Type. File Information Title Scapular Winging as a Symptom of Cervical Flexion My Author(s)Yaguchi, Hiroaki; Takahashi, Ikuko; Tashiro, Jun; Ts CitationInternal Medicine, 46(8): 511-514 Issue Date 2007-04-17 Doc URL http://hdl.handle.net/2115/20467

More information

Movement Disorders. Psychology 372 Physiological Psychology. Background. Myasthenia Gravis. Many Types

Movement Disorders. Psychology 372 Physiological Psychology. Background. Myasthenia Gravis. Many Types Background Movement Disorders Psychology 372 Physiological Psychology Steven E. Meier, Ph.D. Listen to the audio lecture while viewing these slides Early Studies Found some patients with progressive weakness

More information

Please Silence Your Cell Phones. Thank You

Please Silence Your Cell Phones. Thank You Please Silence Your Cell Phones Thank You From Morphology to Molecular Genetics: Role of the Pathologist in Diagnosis of Muscle Disorders Karen M. Weidenheim, M.D. Department of Pathology (Neuropathology),

More information

CUGC for Nemaline myopathy Article pg Abstract pg. 14

CUGC for Nemaline myopathy Article pg Abstract pg. 14 CUGC for Nemaline myopathy Article pg. 2-14 Abstract pg. 14 Clinical utility gene card for: Nemaline myopathy Kristen J Nowak 1*, Mark R Davis 2*, Carina Wallgren-Pettersson 3, Phillipa J Lamont 2 and

More information

Neuromuscular Diseases: Approach to Clinical Diagnosis

Neuromuscular Diseases: Approach to Clinical Diagnosis Neuromuscular Diseases: Approach to Clinical Diagnosis 1 Shannon Venance 1 and Rabi Tawil 2 1 Department of Clinical Neurological Sciences, University of Western Ontario, London, Ontario, Canada 2 University

More information

Laboratory Examination

Laboratory Examination Todd Zimmerman, M.D. 64 year old African American male presents to establish care with PCG. Meds: Norvasc 5 mg daily PMHx: HTN x 20 years, poorly controlled SHx: No tobacco, illicit; rare EtOH ROS: Negative

More information